Low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study-Reference-Cited by-同舟云学术

Low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study

Published:2020-05-27 Issue:15 Volume:126 Page:3438-3447
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cayssials Emilie¹²³^ORCID,Torregrosa‐Diaz Jose¹²,Gallego‐Hernanz Pilar¹,Tartarin Florence²,Systchenko Thomas¹,Maillard Natacha¹,Desmier Déborah¹,Machet Antoine¹^ORCID,Fleck Emmanuel⁴,Corby Anne⁴,Motard Carine⁵,Denis Guillaume⁶,Herbelin André³,Gombert Jean‐Marc³,Roy Lydia⁷,Ragot Stéphanie²,Leleu Xavier¹²,Guilhot François²,Chomel Jean‐Claude⁸^ORCID

Affiliation:

1. Service d'Oncologie Hématologique et Thérapie Cellulaire, CHU Poitiers Poitiers France

2. INSERM CIC 1402, CHU Poitiers Poitiers France

3. INSERM 1082 Poitiers France

4. Service d'Oncologie Hématologique, CH La Rochelle La Rochelle France

5. Service d'Hématologie, CH Niort Niort France

6. Service d'Hématologie, CH Rochefort Rochefort France

7. Service Clinique d'Hématologie Hôpital Henri‐Mondor Creteil France

8. Service de Cancérologie Biologique, CHU Poitiers Poitiers France

Publisher

Wiley

Subject